Company profile: Outset Medical
1.1 - Company Overview
Company description
- Provider of dialysis technology, including the Tablo Hemodialysis System for treating acute and chronic renal failure in hospitals and at home, featuring integrated water purification, touchscreen interface, and multiple dialysis modalities; TabloHub for two-way data transmission and remote patient monitoring; EMR Connect for EMR integration and automated documentation; and TabloCart for device transportation within clinical settings.
Products and services
- EMR Connect: Secure service integrating the Tablo Hemodialysis System with compatible EMR systems, automating documentation by transmitting treatment data directly to the EMR
- Tablo Hemodialysis System: Multi-setting dialysis machine for hospital and home use, treating acute and chronic renal failure, integrating water purification, touchscreen interface, and supporting multiple dialysis modalities
- TabloHub: Cloud-based platform enabling two-way communication to transmit treatment data, facilitate remote patient monitoring, and provide access to treatment information and device diagnostics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Outset Medical
Gambro
HQ: Sweden
Website
- Description: Provider of medical technology developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gambro company profile →
Renibus Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics to prevent and treat kidney disease, with RBT-1 (single-dose IV before elective cardiac surgery to reduce post-operative complications; Phase 3), Veverimer (oral hydrochloric acid binder for orphan diseases), RBT-3 (iron nanoparticle to restore iron and improve blood product use in cardiac surgery and ER), RBT-9 (anti-inflammatory/antioxidant for COVID-19), and RBT-2 (oral antioxidant/antifibrotic to delay CKD).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renibus Therapeutics company profile →
Hemotune
HQ: Switzerland
Website
- Description: Provider of a therapeutic blood purification platform and products: HemoSystem using magnetic beads to selectively remove large biomolecules for conditions like sepsis; HemoBeads with ultra-magnetic cores and affinity binders; HemoDevice, a reusable extracorporeal device; HemoDisposable sterile single-use tubing; and reSEPT Therapy to restore immune balance in septic shock.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemotune company profile →
Judo Bio
HQ: United States
Website
- Description: Provider of precision therapeutics targeting specific cell populations to address genetic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Judo Bio company profile →
LTX
HQ: United States
Website
- Description: Provider of pharmaceutical therapies for critically ill patients, developing an anticoagulant for ICU patients with kidney failure undergoing continuous renal replacement therapy (CRRT), a 24/7 dialysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LTX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Outset Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Outset Medical
2.2 - Growth funds investing in similar companies to Outset Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Outset Medical
4.2 - Public trading comparable groups for Outset Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →